RGEN

REPLIGEN CORP

Healthcare | Mid Cap

$0.45

EPS Forecast

$184.6

Revenue Forecast

The company already released most recent quarter's earnings. We will publish our AI's next quarter's forecast around 2025-12-31
REPLReplimune Group IncTECHBio-techne CorpNVAXNovavax IncCRSPCrispr Therapeutics AgDNLIDenali Therapeutics IncHALOHalozyme Therapeutics IncIOVAIovance Biotherapeutics IncNBIXNeurocrine Biosciences IncMRNAModerna Inc